Forbes William P

Avg. Two Year Performance

No purchase track record
(13%) Avg. Sale Return
(6%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return4%7%4%(10%)(13%)
Sale Success Rate5 of 113 of 106 of 106 of 101 of 7
Drugs » Drug Related Products

EVP Research&Devel & CDO:

Holdings: 95.26K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
(13%) Sale Return    (6%) Compound

Last Three Months:

($428.19K) Net Amount
Buy:0--
Sell:($428.19K)$49.37